News

Filter

Current filters:

BiotechnologyLicensing

26 to 35 of 97217 results

FDA approves Alcon’s Xtoro to treat swimmer’s ear

FDA approves Alcon’s Xtoro to treat swimmer’s ear

18-12-2014

The US Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used…

Acute otitis externaAlcon LaboratoriesAntibiotics and Infectious diseasesHealthNovartisPharmaceuticalRegulationUSAXtoro

Amgen reveals Blincyto price as $178,000 per course

Amgen reveals Blincyto price as $178,000 per course

18-12-2014

USA-based Amgen has revealed its intended pricing for its immunotherapy Blincyto (blinatumomab), which…

AmgenBiotechnologyBlincytoOncologyPricingUSA

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

18-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from…

AmgenAsia-PacificBiotechnologyDanDrit BiotechEli LillyMarkets & MarketingMelCancerVacOncologyVectibixXBiotechXilonix

X-Chem licenses second cardiovascular drug discovery program to Bayer

X-Chem licenses second cardiovascular drug discovery program to Bayer

18-12-2014

Privately-held biotech firm X-Chem has licensed a second drug discovery program to German pharma major…

BayerBiotechnologyCardio-vascularLicensingX-Chem

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

18-12-2014

The annual sales in Europe of Abstral, a rapidly-disintegrating, sublingual formulation of fentanyl,…

AbstralFinancialKyowa Hakko KirinLicensingNeurologicalOrexoPharmaceuticalProStrakanZubsolv

Insulin therapeutics specialist Nutrinia completes $12 million financing round

Insulin therapeutics specialist Nutrinia completes $12 million financing round

18-12-2014

Nutrinia, a developer of oral insulin therapies to treat rare gastrointestinal disorders in babies, has…

Business FinanceEndocrine systemGastro-intestinalsNutriniaPharmaceutical

Eisai's Halaven now available in Russia for advanced breast cancer

Eisai's Halaven now available in Russia for advanced breast cancer

18-12-2014

Halaven (eribulin) manufactured by Japanese drug major Eisai is now available in Russia.

EisaiHalavenOncologyPharmaceuticalRegulationRussia

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

18-12-2014

US biotech company Celgene Corp has made two appointments to its EMEA team.

BiotechnologyBoardroomCelgene CorpCelgene Corp.Stefano Portolano

Lundbeck to stop further development of desmoteplase

Lundbeck to stop further development of desmoteplase

18-12-2014

Following evaluation of disappointing clinical results, Danish CNS specialists Lundbeck said late yesterday…

Cardio-vasculardesmoteplaseFinancialLundbeckNeurologicalPharmaceuticalResearch

26 to 35 of 97217 results

Back to top